Pfizer Antibiotic Patent Escapes Apotex AIA Challenge
A Pfizer Inc. unit's patent covering Tygacil, a drug based on the antibiotic tigecycline, survived an America Invents Act challenge from Apotex Inc. Monday as the Patent Trial and Appeal Board,...To view the full article, register now.
Already a subscriber? Click here to view full article